v3.23.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,956,604 $ 7,188,553
Marketable securities 21,761,564 15,861,620
Accounts receivable 64,521 39,881
Prepaid research and development 923,128 1,117,616
Prepaid expenses and other current assets 922,764 163,452
Total current assets 27,628,581 24,371,122
Equipment and improvements 231,489 236,532
Operating lease right of use assets 303,263 328,643
Total assets 28,163,333 24,936,297
Current liabilities:    
Accounts payable 959,078 1,151,173
Lease obligation, current 146,901 145,836
Accrued expenses and other current liabilities 1,558,221 2,398,436
Total current liabilities 2,664,200 3,695,445
Lease obligation, net of current portion 178,110 205,451
Total liabilities 2,842,310 3,900,896
Commitments and contingencies (see Note 13)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 25,227,051 and 25,155,198 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 31,056 25,227
Additional paid-in capital 77,473,765 68,777,298
Accumulated other comprehensive income 165,822 104,718
Accumulated deficit (52,349,620) (47,871,842)
Total stockholders' equity 25,321,023 21,035,401
Total liabilities and stockholders' equity $ 28,163,333 $ 24,936,297

Source